Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form and Type A Medicated Articles

Краткое содержание

The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form and Type A Medicated Articles" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.